Definitive Healthcare (NASDAQ:DH) Shares Up 11% – Should You Buy?

Definitive Healthcare Corp. (NASDAQ:DH) rose 11% during trading on Tuesday . The stock traded as high as $4.41 and last traded at $4.38. Approximately 105,381 shares changed hands during trading, a decline of 87% from the average daily volume of 826,109 shares. The stock had previously closed at $3.94.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on DH shares. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Barclays restated an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a research report on Monday, January 13th. Finally, Stephens assumed coverage on Definitive Healthcare in a research note on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Definitive Healthcare currently has a consensus rating of “Hold” and a consensus price target of $5.72.

Definitive Healthcare Stock Up 11.3 %

The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The stock has a 50-day moving average of $4.34 and a two-hundred day moving average of $4.47. The company has a market cap of $506.56 million, a P/E ratio of -1.41, a P/E/G ratio of 2.96 and a beta of 1.41.

Insider Activity

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares of the company’s stock, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 14.84% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Rhumbline Advisers grew its position in shares of Definitive Healthcare by 19.7% in the 2nd quarter. Rhumbline Advisers now owns 83,751 shares of the company’s stock worth $457,000 after buying an additional 13,764 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Definitive Healthcare by 50.5% in the second quarter. Renaissance Technologies LLC now owns 28,900 shares of the company’s stock worth $158,000 after acquiring an additional 9,700 shares in the last quarter. Hsbc Holdings PLC bought a new position in Definitive Healthcare in the 2nd quarter worth about $127,000. Canada Pension Plan Investment Board purchased a new position in Definitive Healthcare in the second quarter worth about $109,000. Finally, Marshall Wace LLP bought a new position in shares of Definitive Healthcare in the second quarter worth approximately $1,535,000. Institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.